Magellan Diagnostics
Magellan Biosciences is provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.
Employees
Enterprise value
$66m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor investor | €0.0 | round | |
$66.0m Valuation: $66.0m | Acquisition | ||
| Total Funding | 000k | ||
Boston Community Venture Fund(exited)
New England Partners(exited)
Nexus Medical Partners(exited)
Tekla Capital Management(exited)
Ampersand Capital Partners(exited)
KBL Healthcare Ventures(exited)
Abingworth(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.